IP Library Patent Application 15899844
Patent Application
App. No. 15/899,844

CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/899,844
Abstract

The invention described herein relates to processes for preparing ketolide antibacterial agents. In particular, the invention relates to intermediates and processes for preparing ketolides that include a 1,2,3-triazole substituted side chain.

Claims (35)

1 - 25 . (canceled)

26 . A composition comprising solithromycin that is substantially free of

wherein A-B is (CH 2 ) 4 .

27 . A compound of the formula:

wherein:

A is CH 2 , C(O), C(O)O, C(O)NH, S(O) 2 , S(O) 2 NH, or C(O)NHS(O) 2 ;

B is saturated C 0 C 10 ; or B is unsaturated C 2 C 10 ; or

AB taken together is alkylene, alkenylene, cycloalkylene, or arylene;

C is hydrogen, halogen, hydroxy, acyl, acyloxy, sulfonyl, ureyl, and carbamoyl, and alkyl, alkoxy, heteroalkyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl, each of which is optionally substituted; and

R 100 is hydrogen or a hydroxyl protecting group.

28 . The compound of claim 27 wherein C is aryl, heteroaryl, arylalkyl, or heteroarylalkyl, each of which is optionally substituted.

29 . The compound of claim 27 wherein A is CH 2 .

30 . The compound of claim 27 wherein B is (CH 2 ) n , and n is an integer from 2-6.

31 . The compound of claim 27 of the formula

32 . The compound of claim 27 of the formula

33 . The compound of claim 32 wherein R 100 is hydrogen.

34 . An intermediate of the formulae

wherein:

A is CH 2 , C(O), C(O)O, C(O)NH, S(O) 2 , S(O) 2 NH, or C(O)NHS(O) 2 ;

B is saturated C 0 C 10 ; or B is unsaturated C 2 C 10 ; or

AB taken together is alkylene, alkenylene, cycloalkylene, or arylene;

C is hydrogen, halogen, hydroxy, acyl, acyloxy, sulfonyl, ureyl, and carbamoyl, and alkyl, alkoxy, heteroalkyl, aryl, heteroaryl, arylalkyl, and heteroarylalkyl, each of which is optionally substituted; or C is C P , where C P is a protected form of C;

R 100 is hydrogen or a hydroxyl protecting group; and

N P is NH 2 or protected amino.

35 . The intermediate of claim 34 wherein C is aryl, heteroaryl, arylalkyl, or heteroarylalkyl, each of which is optionally substituted.

36 . The intermediate of claim 34 wherein A is CH 2 .

37 . The intermediate of claim 34 wherein B is (CH 2 ) n , and n is an integer from 2-6.

38 . The intermediate of claim 34 wherein B is (CH 2 ) n , and n is 2, 3, or

4 .

39 . The intermediate of claim 34 wherein R 100 is acyl.

40 . The intermediate of claim 34 of the formula

41 . The intermediate of claim 34 of the formula

42 . The intermediate of claim 34 of the formula

43 . The intermediate of claim 34 of the formula

44 . The intermediate of claim 34 of the formula

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: CEMPRA PHARMACEUTICALS, INC.
Reel/Frame 049363/0706 →
SECURITY INTEREST Recorded Jul 25, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 046454/0392 →